secwatch.observer — SEC 8-K summary
======================================

Issuer:     Journey Medical Corp (DERM)
CIK:        0001867066
Form:       8-K
Filed at:   2022-06-21T23:59:59+00:00
Accession:  0001104659-22-072953
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Journey Medical shareholders approve 3M-share increase to equity plan, re-elect directors
--------------------------------------------------------------------------------

- Shareholders approved amendment to 2015 Stock Plan increasing shares from 4,642,857 to 7,642,857 (a 64.6% increase).
- All six director nominees elected: Rosenwald, Maraoui, Herskowitz, Paley, Smith, Toledano.
- Ratification of KPMG as independent auditor for fiscal 2022 approved with 19,887,190 votes for.
- Plan amendment became effective upon stockholder approval on June 21, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1867066/000110465922072953/0001104659-22-072953-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1867066/000110465922072953/tm2219018d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-072953

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer